# Diindolylmethane in Treating Patients With Abnormal Cervical Cells

> **NCT00462813** · PHASE3 · COMPLETED · sponsor: **Barts and the London School of Medicine and Dentistry** · enrollment: 3000 (estimated)

## Conditions studied

- Cervical Cancer
- Precancerous Condition

## Interventions

- **DRUG:** oral microencapsulated diindolylmethane
- **GENETIC:** polymerase chain reaction
- **OTHER:** cervical Papanicolaou test
- **OTHER:** cytology specimen collection procedure
- **PROCEDURE:** colposcopic biopsy

## Key facts

- **NCT ID:** NCT00462813
- **Lead sponsor:** Barts and the London School of Medicine and Dentistry
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2008-06
- **Final completion:** 2010-01
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2013-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00462813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00462813, "Diindolylmethane in Treating Patients With Abnormal Cervical Cells". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00462813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*